ARWR Latest Headlines

Piper Sandler Remains a Buy on Arrowhead Pharmaceuticals (ARWR)

at www.tipranks.com (Tue, 13-Jan 7:08 AM)

Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes

at www.tipranks.com (Mon, 12-Jan 5:34 PM)

Arrowhead Pharmaceuticals Raises $625M in Convertible Notes and Upsizes Offerings: What Does This Mean for Investors?

Market Chameleon (Thu, 8-Jan 9:33 AM)

Arrowhead’s REDEMPLO Wins Health Canada Approval—A Potential Breakthrough for Rare Lipid Disorder Patients

Market Chameleon (Tue, 6-Jan 11:07 AM)

ARWR Trial Data Shows ARO-INHBE Combination Doubles Weight Loss and Triples Fat Reduction in Obese Diabetics

Market Chameleon (Tue, 6-Jan 7:51 AM)

Arrowhead's Novel RNAi Therapy Targets Alzheimer's at the Genetic Level—Phase 1/2a Study Kicks Off

Market Chameleon (Mon, 8-Dec 7:58 AM)

FDA Breakthrough Therapy Designation for Plozasiran Highlights Arrowhead’s Innovative Approach to Severe Hypertriglyceridemia

Market Chameleon (Tue, 2-Dec 8:36 AM)

FDA Approval and Financial Turnaround Highlight Arrowhead Pharmaceuticals’ Breakout Year

Market Chameleon (Wed, 26-Nov 11:45 AM)